Biovu
-
Neanderthal DNA has subtle but significant impact on human traits
The first study that directly compares Neanderthal DNA in the genomes of a significant population of adults of European ancestry with their clinical records confirms that this archaic genetic legacy has a subtle but significant impact on modern human biology. Read MoreFeb 11, 2016
-
Genetics Institute director Cox set for next Discovery Lecture
Nancy Cox, Ph.D., founding director of the Vanderbilt Genetics Institute, will deliver the next Flexner Discovery Lecture on Thursday, Dec. 17. Read MoreDec 10, 2015
-
Genotyping project to be an ‘engine of discovery’
Vanderbilt University researchers next month will launch a major initiative to acquire “dense genotypes” from 100,000 individuals whose medical histories are known. Read MoreAug 6, 2015
-
Consent process for BioVU participation updated
As of last week, Vanderbilt has updated the process used to facilitate patient participation in BioVU, the Medical Center’s DNA repository. Read MoreJan 29, 2015
-
BioVU to collect plasma in hunt for heart failure clues
Vanderbilt’s biobank, BioVU, has begun to collect and store plasma, the liquid part of blood, to aid studies of diseases ranging from heart failure and hypertension to breast cancer. Read MoreNov 6, 2014
-
Biomarker for diabetic eye disease
A person’s mitochondrial gene “signature” could predict risk for diabetic retinopathy and guide early intervention strategies. Read MoreSep 26, 2014
-
VU, Celgene announce research partnership
Vanderbilt University has formed a scientific partnership with Celgene Corporation to investigate new uses for the company’s anti-inflammatory drugs that are already on the market. Read MoreJul 10, 2014
-
Roden named to NIH’s genomics advisory council
Dan Roden, M.D., assistant vice chancellor for Personalized Medicine, has been appointed to the National Advisory Council for Human Genome Research of the National Institutes of Health (NIH). Read MoreJun 12, 2014
-
E-records shed light on drug response
Electronic medical records linked to DNA biobanks are a valid resource for defining and understanding the genetic factors that contribute to drug response. Read MoreMar 31, 2014
-
A pain in the … genes
Vanderbilt researchers have discovered that variation in the gene encoding the potassium channel GIRK1 plays a role in modulating human pain perception. Read MoreJan 10, 2014
-
Symposium highlights VU’s clinical, translational research
Nearly $5 million in internal pilot grants to jumpstart research projects. A tripling in the number of clinical and translational research publications. Novel research tools that have been snapped up by scientists around the world. Read MoreNov 29, 2012
-
VUMC’s Denny lands award from informatics group
Joshua Denny, M.D., M.S., assistant professor of Biomedical Informatics and Medicine and a key contributor to Vanderbilt University’s personalized medicine initiative, is the 2012 recipient of the New Investigator Award from the American Medical Informatics Association (AMIA). Read MoreNov 8, 2012
-
AAMC meet highlights need for research funds
During a meeting in Nashville last week, the director of the National Institutes of Health (NIH) called on academic medical centers to make the case for continued, strong federal investment in biomedical research. Read MoreSep 27, 2012
-
Dan Roden: “Genomes, Hype, and a Realistic Pathway to Personalized Medicine”
Watch video of the Chancellor’s Lecture Series, featuring a talk by Dr. Dan Roden: “Genomes, Hype, and a Realistic Pathway to Personalized Medicine” Roden is widely-recognized for his expertise in clinical, genetic, cellular, and molecular basis of arrhythmia susceptibility and variability responses to arrhythmia therapies. Over the past decade, he… Read MoreSep 12, 2012
-
BioVU reaches new benchmark in DNA samples
This month BioVU logged in its 150,000th unique genetic sample. It is now the world’s largest collection of human DNA linked to searchable, electronic health information. Read MoreSep 6, 2012
-